HealthEquity, Inc. (NASDAQ:HQY) Q2 2023 Earnings Conference Call September 6, 2022 4:30 PM ET

Corporate Participants

Richard Putnam - Investor Relations

Jon Kessler - President and Chief Executive Officer

Tyson Murdock - Executive Vice President and Chief Financial Officer

Steve Neeleman - Vice-Chair and Founder

Conference Call Participants

Gregory Peters - Raymond James

Allen Lutz - Bank of America

Stephanie Davis - SVB Securities

David Larsen - BTIG

Glen Santangelo - Jefferies

Stan Bernstein - Wells Fargo

Sandy Draper - Guggenheim

Sean Dodge - RBC

Cindy Motz - Goldman Sachs

Mark Marcon - Baird

Richard Putnam

[Call Starts Abruptly] Second Quarter Fiscal Year 2023 Earnings Conference Call. My name is Richard Putnam. And I do Investor Relations here for HealthEquity. Joining me today, we have Jon Kessler, who is our President and CEO; Dr. Steve Neeleman, who is our Vice-Chair and Founder of the Company; and Tyson Murdock, the company's Executive Vice President and CFO.

Before I turn the call over to Jon, I have two important reminders. First, a press release announcing our financial results for the second quarter of fiscal year 2023 was issued after the market closed this afternoon. The financial results in the press release include contributions from our wholly owned subsidiary WageWorks and the accounts it administers. The press release also includes definitions of certain non-GAAP financial measures that we will reference here today. A copy of today's press release, including reconciliations of these non-GAAP measures with comparable GAAP measures and a recording of the webcast can be found on our Investor Relations website, which is ir.healthequity.com.

Second, our comments and responses to your questions today reflect management's view as of today September 6, 2022 and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business, which could affect the forward-looking statements made today. These forward-looking statements are subject to risks and uncertainties that may cause the actual results to differ materially from the statements made here today.

We caution you against placing undue reliance on these forward-looking statements and we also encourage you to review the discussion of these factors as well as other risk factors that may affect our future results, or the market price of our stock and they are detailed in our latest Annual Report on Form 10-K and subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events.